ADVT

(redirected from Acute Deep Vein Thrombosis)
AcronymDefinition
ADVTAdvertisement
ADVTAdvertising (college course)
ADVTAverage Daily Volume Traded (investing)
ADVTAcquirer Device Validation Toolkit
ADVTAcute Deep Vein Thrombosis
ADVTAdvance Development Verification Test
References in periodicals archive ?
Fondaparinux is currently approved for use in the EU for the prevention of venous thromboembolic events (VTE), initial treatment of acute deep vein thrombosis (DVT), pulmonary embolism (PE) treatment of unstable angina or non-ST segment elevation myocardial infarction (UA/NSTEMI) and for the treatment of ST segment elevation myocardial infarction (STEMI).
Early mobilization in patients with acute deep vein thrombosis: does it increase the incidence of symptomatic pulmonary embolism?
Pregnant women were hospitalized for an average of 6.4 days to treat acute deep vein thrombosis, and postpartum women were hospitalized for an average of 9.1 days.
Ruling out acute deep vein thrombosis by ELISA plasma D-dimer assay versus ultrasound in inpatients more than 70 years old.
Boehringer Ingelheim today announced the submission of an application to the European Medicines Agency (EMA) for use of Pradaxa (dabigatran etexilate) for the treatment of acute deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of recurrent DVT and PE.
In the trial, 1,240 patients with acute deep vein thrombosis received ximelagatran (36 mg twice daily) and 1,249 patients received standard therapy with enoxaparin for 5 days followed by warfarin for 6 months.
Full browser ?